Clinical issues in diagnosis and treatment of hyperprolactinemia

Sun Fei; Gao Bin

doi:10.13406/j.cnki.cyxb.003337

您当前的位置：

首页 >

文章列表页 >

Clinical issues in diagnosis and treatment of hyperprolactinemia

Hypothalamic pituitary gland and wound repair diseases | 更新时间：2025-10-21

- Clinical issues in diagnosis and treatment of hyperprolactinemia
- Journal of Chongqing Medical University Vol. 48, Issue 9, Pages: 1042-1045(2023)
- 作者机构：
  
  空军军医大学第二附属医院内分泌科，西安 710038
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.003337
  CLC： R584.1
- Received：02 August 2023，
  
  Revised：2023-08-10，
  
  Accepted：04 September 2023，
  
  Published：28 September 2023
- 稿件说明：
移动端阅览
孙飞,高彬.高泌乳素血症诊治若干临床问题探讨[J].重庆医科大学学报,2023,48(9):1042-1045.

Sun Fei,Gao Bin.Clinical issues in diagnosis and treatment of hyperprolactinemia[J].Journal of Chongqing Medical University,2023,48(9):1042-1045.
孙飞,高彬.高泌乳素血症诊治若干临床问题探讨[J].重庆医科大学学报,2023,48(9):1042-1045. DOI： 10.13406/j.cnki.cyxb.003337.

Sun Fei,Gao Bin.Clinical issues in diagnosis and treatment of hyperprolactinemia[J].Journal of Chongqing Medical University,2023,48(9):1042-1045. DOI： 10.13406/j.cnki.cyxb.003337.

摘要

高泌乳素血症是继发性性腺功能减退的常见原因，影响男性及女性的生殖功能，目前高泌乳素血症的诊治存在较多挑战。在激素测定方面存在低估激素真实水平的“钩状效应”，无症状或与症状不相符的高泌乳素水平为特点的巨泌乳素血症；在诊断时应注意鉴别生理性、病理性或药物性这三大常见原因从而减少误诊、漏诊；多巴胺受体激动剂是一线治疗，但对于耐药的高泌乳素血症应在全面评估病情后选择外科手术、放疗及其他药物的试验性治疗（如替莫唑胺）等；妊娠阶段是泌乳素生理性分泌增加的时期，不建议孕期应用泌乳素测定评价病情，主要通过有无肿瘤占位效应及病情危急情况决定是否需要启动药物或手术治疗。对于耐药/难治性高泌乳素血症及妊娠期高泌乳素血症的诊疗建议在有经验的多学科诊疗团队支持下进行。

Abstract

Hyperprolactinemia is a common cause of secondary hypogonadism，which affects the reproductive function of both men and women. There are many challenges in the diagnosis and treatment of hyperprolactinemia. There is a ‘hook effect’ in the measurement of hormone levels，which underestimates the true level of hormone. Macroprolactinemia is characterized by asymptomatic or inconsistent high prolactin levels. In order to reduce misdiagnosis and missed diagnosis，attention should be paid to distinguish the three common causes of physiological，pathological or drug. Dopamine receptor agonist is the first-line treatment，but for patients with drug-resistant hyperprolactinemia，surgery，radiotherapy and other drug trials （such as temozolomide） should be selected after a comprehensive evaluation of the condition. Pregnancy is a period of increased physiological secretion of prolactin，and it is not recommended to use prolactin measurement to evaluate the disease during pregnancy. It is mainly determined by the tumor mass effect and critical condition to decide whether to start drug or surgical treatment. The diagnosis and treatment of resistant/refractory hyperprolactinemia and hyperprolactinemia during pregnancy are recommended under the support of an experienced multidisciplinary team.

关键词

Keywords

references

Vilar L ， Vilar CF ， Lyra R ， et al . Pitfalls in the Diagnostic Evaluation of Hyperprolactinemia [J ] . Neuroendocrinology ， 2019 ， 109 （ 1 ）： 7 - 19 .

Donato J ， Frazão R . Interactions between prolactin and kisspeptin to control reproduction [J ] . Archives of endocrinology and metabolism ， 2016 ， 60 （ 6 ）： 587 - 595 .

Shibli-Rahhal A ， Schlechte J . Hyperprolactinemia and infertility [J ] . Endocrinology and metabolism clinics of North America ， 2011 ， 40 （ 4 ）： 837 - 46 .

Demura R ， Ono M ， Demura H ， et al . Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 17 beta-estradiol in the human ovary [J ] . The Journal of clinical endocrinology and metabolism ， 1982 ， 54 （ 6 ）： 1246 - 1250 .

Dabbous Z ， Atkin SL . Hyperprolactinaemia in male infertility： Clinical case scenarios [J ] . Arab journal of urology . 2018 ; 16 （ 1 ）： 44 - 52 .

Freeman ME ， Kanyicska B ， Lerant A ， et al . Prolactin： structure，function，and regulation of secretion [J ] . Physiological reviews ， 2000 ， 80 （ 4 ）： 1523 - 12631 .

Fleseriu M ， Lee M ， Pineyro MM ， et al . Giant invasive pituitary prolactinoma with falsely low serum prolactin： the significance of 'hook effect' [J ] . Journal of neuro-oncology ， 2006 ， 79 （ 1 ）： 41 - 43 .

Fahie-Wilson MN ， John R ， Ellis AR . Macroprolactin; high molecular mass forms of circulating prolactin [J ] . Annals of clinical biochemistry ， 2005 ， 42 （ Pt 3 ）： 175 - 192 .

Smith TP ， Suliman AM ， Fahie-Wilson MN ， et al . Gross variability in the detection of prolactin in sera containing big big prolactin（macroprolactin） by commercial immunoassays [J ] . The Journal of clinical endocrinology and metabolism ， 2002 ， 87 （ 12 ）： 5410 - 5415 .

Fahie-Wilson M ， Smith TP . Determination of prolactin： the macroprolactin problem [J ] . Best practice & research. Clinical endocrinology & metabolism ， 2013 ， 27 （ 5 ）： 725 - 742 .

中华医学会神经外科学分会，中华医学会妇产科学分会，中华医学会内分泌学分会 . 高催乳素血症诊疗共识 [J ] . 中华医学杂志， 2011 ，（ 3 ）： 147 - 154 .

Chinese Society of Neurosurgery ， Chinese Society of Obstetrics and Gynecology ， Chinese Society of Endocrinology . Consensus on diagnosis and treatment of hyperprolactinemia [J ] . National Medical Journal of China ， 2011 ，（ 3 ）： 147 - 154 .

Melmed S ， Casanueva FF ， Hoffman AR ， et al . Diagnosis and treatment of hyperprolactinemia： an Endocrine Society clinical practice guideline [J ] . The Journal of clinical endocrinology and metabolism ， 2011 ， 96 （ 2 ）： 273 - 288 .

Casanueva FF ， Molitch ME ， Schlechte JA ， et al . Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas [J ] . Clinical endocrinology ， 2006 ， 65 （ 2 ）： 265 - 273 .

Cozzi R ， Simona Auriemma R ， De Menis E ， et al . Italian guidelines for the management of prolactinomas [J ] . Endocrine ，metabolic & immune disorders drug targets， 2023 .

中华医学会妇产科学分会内分泌学组 . 女性高催乳素血症诊治共识 [J ] . 中华妇产科杂志， 2016 ， 51 （ 3 ）： 161 - 168 .

EndocrinologyGroup，Society of Obstetrics and Gynecology，Chinese Medical Association . Consensus on diagnosis and treatment of hyperprolactinemia in women [J ] . Chinese Journal of Obstetrics and Gynecology . 2016 ， 51 （ 3 ）： 161 - 168 .

Vilar L ， Abucham J ， Albuquerque JL ， et al . Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism [J ] . Archives of endocrinology and metabolism ， 2018 ， 62 （ 2 ）： 236 - 263 .

Urwyler SA ， Karavitaki N . Refractory lactotroph adenomas [J ] . Pituitary ， 2023 ， 26 （ 3 ）： 273 - 277 .

Glezer A ， Bronstein MD . Prolactinomas in pregnancy： considerations before conception and during pregnancy [J ] . Pituitary ， 2020 ， 23 （ 1 ）： 65 - 69 .

Luger A ， Broersen LHA ， Biermasz NR ， et al . ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy [J ] . European journal of endocrinology ， 2021 ， 185 （ 3 ）： G1 - g33 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Cellular senescence and pregnancy

Biomarkers and treatment options for immune checkpoint blockade resistance in pancreatic ductal adenocarcinoma

Research advances in the biological characteristics of male patients with prolactinoma

Application analysis of radiofrequency ablation for monochorionic triplet pregnancy

Research advances in the mechanism of exosomes derived from cancer-associated fibroblasts in regulating tumor drug resistance

Related Author

Hu Die

Liu Jianing

Feng Xiaoling

Ren Jiajie

Guo Luqin

Yin Yanmei

Li Jing

Wang Hu

Related Institution

Department Two of Gynecology，First Affiliated Hospital of Heilongjiang University of Chinese Medicine

Graduate School，Heilongjiang University of Chinese Medicine

The First Clinical Medical College of Lanzhou University

Department of Neurosurgery，The Second Affiliated Hospital of Army Medical University

Department of Obstetrics，The First Affiliated Hospital of Chongqing Medical University

⁰